IBDEI2SQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46939,1,3,0)
 ;;=3^Asthma NEC
 ;;^UTILITY(U,$J,358.3,46939,1,4,0)
 ;;=4^J45.998
 ;;^UTILITY(U,$J,358.3,46939,2)
 ;;=^5008257
 ;;^UTILITY(U,$J,358.3,46940,0)
 ;;=J43.8^^206^2315^15
 ;;^UTILITY(U,$J,358.3,46940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46940,1,3,0)
 ;;=3^Emphysema NEC
 ;;^UTILITY(U,$J,358.3,46940,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,46940,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,46941,0)
 ;;=J43.1^^206^2315^28
 ;;^UTILITY(U,$J,358.3,46941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46941,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,46941,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,46941,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,46942,0)
 ;;=J45.51^^206^2315^29
 ;;^UTILITY(U,$J,358.3,46942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46942,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,46942,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,46942,2)
 ;;=^5008252
 ;;^UTILITY(U,$J,358.3,46943,0)
 ;;=J45.52^^206^2315^30
 ;;^UTILITY(U,$J,358.3,46943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46943,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,46943,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,46943,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,46944,0)
 ;;=J45.50^^206^2315^31
 ;;^UTILITY(U,$J,358.3,46944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46944,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,46944,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,46944,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,46945,0)
 ;;=J43.0^^206^2315^32
 ;;^UTILITY(U,$J,358.3,46945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46945,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,46945,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,46945,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,46946,0)
 ;;=J45.901^^206^2315^3
 ;;^UTILITY(U,$J,358.3,46946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46946,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,46946,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,46946,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,46947,0)
 ;;=J45.902^^206^2315^4
 ;;^UTILITY(U,$J,358.3,46947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46947,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,46947,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,46947,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,46948,0)
 ;;=J45.909^^206^2315^5
 ;;^UTILITY(U,$J,358.3,46948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46948,1,3,0)
 ;;=3^Asthma,Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,46948,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,46948,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,46949,0)
 ;;=J42.^^206^2315^13
 ;;^UTILITY(U,$J,358.3,46949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46949,1,3,0)
 ;;=3^Chr Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,46949,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,46949,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,46950,0)
 ;;=I95.1^^206^2316^1
 ;;^UTILITY(U,$J,358.3,46950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46950,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,46950,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,46950,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,46951,0)
 ;;=I73.9^^206^2316^2
 ;;^UTILITY(U,$J,358.3,46951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46951,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,46951,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,46951,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,46952,0)
 ;;=I80.13^^206^2316^3
 ;;^UTILITY(U,$J,358.3,46952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46952,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Femoral Vein
